Deutsche Bank Reiterates a buy rating on Mead Johnson Nutrition MJN and lowered its price target from $88 to $85.
Deutsche Bank commented, “Our history with global CPG leaders is that opportunities to purchase their stock on weakness are rare. We see the market's fixation on China today vs. Mead's and the category's excellent LT prospects as a compelling entry point. We view valuation vs. global CPG peers (share leaders, solid returns) as relatively attractive and retain a BUY opinion”
Mead Johnson Nutrition closed at $70.69 on Thursday.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in